Lewis, the host of the 1990s MTV show “Hot Zone,” tried to fight her illness without undergoing a double mastectomy. She says she is responding well after resuming treatment.The former MTV V.J. Ananda Lewis said in a CNN round-table discussion that was posted online on Tuesday that her breast cancer, which she first learned she had in 2019, metastasized last year and had reached Stage 4.In a phone interview with The New York Times on Wednesday, Lewis, 51, said that she had since resumed treatment and was feeling much better. “I’ve turned it around really beautifully,” she said.Lewis first became recognizable in the 1990s as a host of “Teen Summit,” a long-running weekly live show on BET that aimed to speak to Black teenagers about current issues (Lewis interviewed Hillary Clinton, who was then the first lady, on the program in 1996). She went on to host “Hot Zone,” an MTV show in which she interviewed stars and gave style advice. The Times, in a 1999 profile, described her as one of MTV’s most popular stars and “the hip-hop generation’s reigning It Girl.”Stage 4 breast cancer means that the cancer cells have spread beyond the breast, often traveling to the bones, the lungs and the liver. It can be treated with tools like chemotherapy and hormone therapy, but it is considered incurable. Breast cancer is the second most common cancer among women in the United States and a leading cause of death from cancer among women globally.In the round-table — with the CNN correspondent Stephanie Elam, Lewis’s best friend since they met at Howard University in the 1990s, and the CNN anchor Sara Sidner, who had a double mastectomy this year after learning that she had Stage 3 breast cancer — Lewis said that she had decided not to get a double mastectomy despite her doctors’ recommendation in early 2019, when she first discovered the lump and learned she had Stage 3 breast cancer.She sought conventional care after receiving the initial diagnosis, speaking to “the right and best oncologists, the breast surgeons,” she said on Wednesday. As she told Elam, “I decided to keep my tumor and try to work it out of my body a different way.”We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe.

Lucy Letby gave a baby 10 times the prescribed dose of morphine “in error” two years before her killing spree began, a public inquiry has heard.

Getty ImagesAsking aeroplane passengers not to eat nuts is unlikely to prevent an allergic reaction mid-flight – but cleaning their seat with a wet wipe could, allergy specialists say in a review of the latest evidence.

My Name’5 Doddie FoundationWhen Scott Stewart was diagnosed with motor neurone disease (MND), he knew he wanted to keep working to support his family.

The Archbishop of Canterbury has called the idea of assisted dying “dangerous” and suggested it would lead to a “slippery slope” where more people would feel compelled to have their life ended medically.

An urgent review is needed to make sure people in England can get weight loss jabs such as Wegovy and Mounjaro on the NHS, top experts warn.

BBCJob coaches will visit seriously ill patients on mental health wards to try to get them back to work, the government has said.

The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will study the impact of a weight-loss drug on work and productivity.Around one in four adults in Britain is obese, according to estimates from the country’s National Health Service, and the problem costs the public health care system billions every year.Now, the government says that weight-loss injections might be part of the solution, and might even help boost Britain’s productivity, which has been sluggish for years.Studies show that people with obesity are more likely to find that ill health affects their productivity and attendance at work.On Monday, the government announced a 279 million pound (around $365 million) investment from the pharmaceutical company Eli Lilly. Among other things, the investment will help explore new ways of delivering health services to people living with obesity, and include a five-year trial of the company’s drug tirzepatide, also known as Mounjaro, which is used to treat diabetes and for weight loss.The trial, in the Greater Manchester area in northern England, will study the effectiveness of tirzepatide in bringing about weight loss, preventing diabetes and tackling obesity-related health conditions. It will also aim to collect data on whether the drug leads to changes in participants’ employment status and sick days from work, according to a statement from the Health Innovation Network, the innovation arm of the N.H.S.The government said that up to 3,000 people could eventually take part in the study.Prime Minister Keir Starmer, speaking to BBC Breakfast on Tuesday, said he believed the drugs could be “very important for our economy and for health,” adding that tirzepatide “will be very helpful to people who want to lose weight, need to lose weight, very important for the economy so people can get back into work.”We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe.

Getty ImagesSir Keir Starmer and his health secretary have been

Lisa HawkerThe family of a young girl say her life was saved after a pioneering study was able to diagnose her incredibly rare genetic disorder, leading to better treatment.